Clinical Trial Update: Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects [Phase 1]

View source ↗

Summary

A Phase 1 safety and tolerability study of HTC-867 in healthy Japanese volunteers has been completed. Schizophrenia is listed as the related condition in the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• HTC-867

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED